Parsing the Functional Heterogeneity of the Psychosis Spectrum: A Clinically Informed Application of Genomic Structural Equation Modeling
- 1Department of Life Sciences University of Trieste
Abstract
Schizophrenia, bipolar disorder, and major depression vary in their age of onset, cognitive impacts, degree of impairment, and clinical course. However, since psychosis is a transdiagnostic feature that occurs across all three of these disorders, they can be represented as a spectrum. We leveraged genomic data to explore different functionally distinct components of the psychosis spectrum. We used Genomic Structural Equation Modelling (Genomic SEM) to define four factors indexing specific aspects of psychosis-related symptoms shared across depression, schizophrenia, and bipolar disorder: a general Psychosis factor with low Cognitive functionality (gPsychosisCognition), a specific Psychosis factor independent of cognition (sPsychosis), a specific Affective factor independent of psychosis (sAffective) and a specific Mania factor independent of depression (sMania). We then used Stratified Genomic SEM and transcriptomic analyses to characterize biological functions and temporal trends associated with these factors. sPsychosis, sAffective, and sMania exhibited differential genetic correlations with personality, with sPsychosis and sAffective showing positive correlations with Openness, while Neuroticism showed a strong positive correlation with sAffective and a negative correlation for sMania. GABAergic, cortical, and CA1-CA3 enrichments were significant across the continuum with evidence for factor specific enrichment: dentate gyrus, CA4 and cerebellum were non-significant only for sAffective and oligodendrocytes enriched only in gPsychosisCognition. Transcriptomic analyses revealed different temporal expression trends across factors, identifying a mostly prenatal expression for sMania and sAffective, and more consistent expression across development for sPsychosis. We demonstrated that a clinically informed genomic model can shed light on the functional heterogeneity of psychosis, identify both unique and shared biological components and highlight its partial neurodevelopmental origin.
Related
- Resting-State Functional Connectivity in Antipsychotic-Naïve First-Episode Psychosis: A Systematic Review of Network Alterations and Preprocessing Heterogeneity
- Disentangling global atrophy burden from local structural patterns reveals clinically relevant heterogeneity in mild cognitive impairment.
- Evaluation of Structural and Functional Outcomes After the Application of an Initial Single Dose of Faricimab
- Latent Brain-Symptom Dimensions Characterize Heterogeneity in Clinical High Risk for Psychosis
- Neuroimaging of Clinical High-Risk Youth From the Kenya Psychosis-Risk Outcomes Study (KePROS): Regional Structural Analyses and Vertexwise Cortical Deviation Mapping (VCDM)
BibTeX
@misc{sclisizzo2026parsing,
title = {{Parsing the Functional Heterogeneity of the Psychosis Spectrum: A Clinically Informed Application of Genomic Structural Equation Modeling}},
author = {L. Sclisizzo and D. A. Baranger and M. L. Clapp Sullivan and A. S. Hatoum and M. Del Giudice and E. C. Johnson},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.08.26362224},
url = {https://www.medrxiv.org/content/10.64898/2026.09.08.26362224v1},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - Parsing the Functional Heterogeneity of the Psychosis Spectrum: A Clinically Informed Application of Genomic Structural Equation Modeling
AU - L. Sclisizzo
AU - D. A. Baranger
AU - M. L. Clapp Sullivan
AU - A. S. Hatoum
AU - M. Del Giudice
AU - E. C. Johnson
PY - 2026
DA - 2026/09/08
PB - medRxiv
DO - 10.64898/2026.09.08.26362224
UR - https://www.medrxiv.org/content/10.64898/2026.09.08.26362224v1
AB - Schizophrenia, bipolar disorder, and major depression vary in their age of onset, cognitive impacts, degree of impairment, and clinical course. However, since psychosis is a transdiagnostic feature that occurs across all three of these disorders, they can be represented as a spectrum. We leveraged genomic data to explore different functionally distinct components of the psychosis spectrum. We used Genomic Structural Equation Modelling (Genomic SEM) to define four factors indexing specific aspects of psychosis-related symptoms shared across depression, schizophrenia, and bipolar disorder: a general Psychosis factor with low Cognitive functionality (gPsychosisCognition), a specific Psychosis factor independent of cognition (sPsychosis), a specific Affective factor independent of psychosis (sAffective) and a specific Mania factor independent of depression (sMania). We then used Stratified Genomic SEM and transcriptomic analyses to characterize biological functions and temporal trends associated with these factors. sPsychosis, sAffective, and sMania exhibited differential genetic correlations with personality, with sPsychosis and sAffective showing positive correlations with Openness, while Neuroticism showed a strong positive correlation with sAffective and a negative correlation for sMania. GABAergic, cortical, and CA1-CA3 enrichments were significant across the continuum with evidence for factor specific enrichment: dentate gyrus, CA4 and cerebellum were non-significant only for sAffective and oligodendrocytes enriched only in gPsychosisCognition. Transcriptomic analyses revealed different temporal expression trends across factors, identifying a mostly prenatal expression for sMania and sAffective, and more consistent expression across development for sPsychosis. We demonstrated that a clinically informed genomic model can shed light on the functional heterogeneity of psychosis, identify both unique and shared biological components and highlight its partial neurodevelopmental origin.
ER -